These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19051519)

  • 1. Pharmacy initiatives target prescription drug costs.
    Stafford E
    J Mich Dent Assoc; 2008 Sep; 90(9):22. PubMed ID: 19051519
    [No Abstract]   [Full Text] [Related]  

  • 2. How Pharmacy Benefit Managers Add to Financial Toxicity: The Copay Accumulator Program.
    Nabhan C; Phillips EG; Feinberg BA
    JAMA Oncol; 2018 Dec; 4(12):1665-1666. PubMed ID: 30286215
    [No Abstract]   [Full Text] [Related]  

  • 3. Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa.
    Mpanza NM; Bradley H; Laing R
    Afr J Prim Health Care Fam Med; 2019 Mar; 11(1):e1-e6. PubMed ID: 31038333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captive markets.
    Mettner J
    Minn Med; 2008 Nov; 91(11):12-3. PubMed ID: 19108536
    [No Abstract]   [Full Text] [Related]  

  • 5. Health Insurers Often Foot Bill When Drug Coupons Are Used.
    Wolinsky H
    Manag Care; 2017 Mar; 26(3):38-39. PubMed ID: 28510519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Pharmacy Benefit Managers on Drug Pricing.
    Patel DJ; Bhatia N; Kaufmann MD
    J Drugs Dermatol; 2020 Sep; 19(9):900-903. PubMed ID: 33026747
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle.
    Dusetzina SB; Bach PB
    JAMA; 2019 Apr; 321(16):1563-1564. PubMed ID: 30840047
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacy team involvement in navigating the revenue cycle for high-cost medications in patients with cancer.
    Shank BR; Nguyen PAA; Pherson EC
    Am J Manag Care; 2017 Oct; 23(12 Spec No.):SP470-SP473. PubMed ID: 29087665
    [No Abstract]   [Full Text] [Related]  

  • 9. How to get the most out of your insurance dollar.
    Gonser G
    J Mass Dent Soc; 2002; 51(3):42. PubMed ID: 12380040
    [No Abstract]   [Full Text] [Related]  

  • 10. Lower your drug costs.
    Santa J
    Consum Rep; 2009 Jun; 74(6):13. PubMed ID: 19455768
    [No Abstract]   [Full Text] [Related]  

  • 11. Plans clamp down on utilization and doctors' tempers flare.
    Carroll J
    Manag Care; 2009 Sep; 18(9):31-4. PubMed ID: 19886206
    [No Abstract]   [Full Text] [Related]  

  • 12. Patients, HMO win with cheaper drug.
    Manag Care; 2009 Sep; 18(9):59. PubMed ID: 19886210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug coupons don't always save money.
    Consum Rep; 2009 Feb; 74(2):13. PubMed ID: 19306503
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania.
    Paulozzi LJ; Stier DD
    J Public Health Policy; 2010 Dec; 31(4):422-32. PubMed ID: 21119649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do health plans have a role in limiting antibiotic resistance?
    Burns J
    Manag Care; 2014 Apr; 23(4):26-30, 32-3. PubMed ID: 24864530
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is prescription of a therapy costing 150,000 CHF reasonable?].
    Peters S; von Moos R; Thurlimann B
    Rev Med Suisse; 2015 Oct; 11(491):1967-72. PubMed ID: 26672265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the demand for prescription drugs: heterogeneity in price responses.
    Skipper N
    Health Econ; 2013 Jul; 22(7):857-69. PubMed ID: 22899231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialty pharmaceuticals: policy initiatives to improve assessment, pricing, prescription, and use.
    Robinson JC; Howell S
    Health Aff (Millwood); 2014 Oct; 33(10):1745-50. PubMed ID: 25288418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.